Barry M. Deutsch
Director of Finance/CFO at Aerami Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anne Michelle Whitaker | F | 56 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 6 years |
| John Stuart Patton | M | 77 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 15 years |
| Steven T. Thornton | M | 67 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 7 years |
| Joshua Ziel | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 2 years |
| Darlene Deptula-Hicks | F | 66 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 3 years |
| Adam Stern | M | 60 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 10 years |
| Bill Welch | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | - |
| Mei-Chang Kuo | M | 75 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert P. L. Stroucken | M | 76 | 4 years | |
| Gail Fosler | F | 76 | 4 years | |
| Amy Pott | F | 47 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 12 years |
| Scott Applebaum | M | 57 | 2 years | |
| Kongkiat Opaswongkarn | M | 67 |
The Wharton School of the University of Pennsylvania
| 6 years |
| Ludwig Hantson | M | 61 | 1 years | |
| Robert Hombach | M | 58 | 1 years | |
| Beth Hecht | F | 60 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Christoph Brackmann | M | - | - | |
| Marla Persky | F | 68 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Donna M. Walsh | F | - |
The Wharton School of the University of Pennsylvania
| 14 years |
| Sotirios G. Stergiopoulos | M | 52 | - | |
| Eric Schwartz | M | 61 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Richard Philip Furst | M | 60 |
Kellogg School of Management
The Wharton School of the University of Pennsylvania
| 7 years |
| Allison Wey | F | - |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Dawn Halkuff | F | 53 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| James R. Gavin | M | 78 | 1 years | |
| John Schmid | M | 61 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 4 years |
| Karen Ferrante | M | 66 | 1 years | |
| Scott W. Meacham | M | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 8 years |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Gregg David Pollack | M | 62 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Andrea Hunt | F | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 29 years |
| Matthew David Ginsburg | M | 60 |
Kellogg School of Management
| 3 years |
| Barbara-Jean Bormann-Kennedy | M | 65 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Stephanie Dorn Miller | F | 50 | 1 years | |
| Jacques Suzanne | F | 53 | 4 years | |
| Jacob Wallenberg | M | 68 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Robert Davis | M | 57 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 6 years |
| Ian Clark | M | 62 | 2 years | |
| Blake E. Devitt | M | 77 | 1 years | |
| Jonathan Rigby | M | 56 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Francois Nader | M | 67 | 1 years | |
| Jeffrey Sherman | M | 69 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Sanjiv Sobti | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Bill Gantz | M | 86 |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | - |
| John D. Forsyth | M | 76 | 1 years | |
| Lisa Yañez | F | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 1 years |
| Mark Thierer | M | 64 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 1 years |
| Glenn Fuhrman | M | 58 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Sean Nolan | M | 56 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 5 years |
| Scott Pinkus | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Marc A. Utay | M | 64 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeffrey Whitnell | M | 68 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 2 years |
| Bob Petit | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Richard Diamond, | - | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Richard Diamond | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| David Abrams | M | 57 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Lilian Díaz-Bento | F | 57 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Petros Papathanasiou | M | 59 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Nicholas Parry Jones | M | 65 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Wai Lun Ip | M | 68 |
The Wharton School of the University of Pennsylvania
| - |
| Pascall Isbell | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Edwin R Kraft | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrew Clark | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Frank Lee | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Judy Krandel | F | 59 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jon Erickson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Michael McChesney | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Darius Lilaoonwala | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Stephen Galowitz | M | 60 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Celia Chapman | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Joseph Stilwell | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Desiree DeStefano | F | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Todd Thomson | M | 63 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Mark Sherman | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Adam K. Bernstein | M | 60 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeff Russell | M | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Robert Ellsworth Butman | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Derek Robert Stone | M | 66 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Fernando Torres-Torija | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Ray Scanlan | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Rob Stavis | M | 61 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Timothy Purcell | M | 65 |
The Wharton School of the University of Pennsylvania
| 2 years |
| James Simms | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| David Kratochvil | M | 58 |
The Wharton School of the University of Pennsylvania
| 4 years |
| David Oppenheimer | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Howard Irwin Fischer | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Steven S. Siegel | M | 61 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeffrey Warshaw | M | 60 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Harvey Ira Hanerfeld | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Christopher Dewey | M | 80 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Matthew I. Roslin | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Eric Kenneth Seiff | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| Haruo Kawamura | M | 66 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Eric Aboaf | M | 67 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Gady Nemirovsky | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Chung-Yuen S. Kwan | M | 65 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Sylvia Brown | F | - |
The Wharton School of the University of Pennsylvania
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 96.94% |
| Ireland | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry M. Deutsch
- Personal Network
